Literature DB >> 19721018

Effects of a Mediterranean-style diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes: a randomized trial.

Katherine Esposito1, Maria Ida Maiorino, Miryam Ciotola, Carmen Di Palo, Paola Scognamiglio, Maurizio Gicchino, Michela Petrizzo, Franco Saccomanno, Flora Beneduce, Antonio Ceriello, Dario Giugliano.   

Abstract

BACKGROUND: Low-carbohydrate and low-fat calorie-restricted diets are recommended for weight loss in overweight and obese people with type 2 diabetes.
OBJECTIVE: To compare the effects of a low-carbohydrate Mediterranean-style or a low-fat diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes.
DESIGN: Single-center, randomized trial. Randomization was computer-generated and unstratified. Allocation was concealed in sealed study folders held in a central, secure location until participants gave informed consent. Participants and investigators were aware of treatment assignment, and assessors of the primary outcome were blinded.
SETTING: Teaching hospital in Naples, Italy. PATIENTS: 215 overweight people with newly diagnosed type 2 diabetes who were never treated with antihyperglycemic drugs and had hemoglobin A(1c) (HbA(1c)) levels less than 11%. INTERVENTION: Mediterranean-style diet (<50% of daily calories from carbohydrates) (n = 108) or a low-fat diet (<30% of daily calories from fat) (n = 107). MEASUREMENTS: Start of antihyperglycemic drug therapy, defined by protocol as indicated for follow-up HbA(1c) level greater than 7% (primary outcome), and changes in weight, glycemic control, and coronary risk factors (secondary outcomes).
RESULTS: After 4 years, 44% of patients in the Mediterranean-style diet group and 70% in the low-fat diet group required treatment (absolute difference, -26.0 percentage points [95% CI, -31.1 to -20.1 percentage points]; hazard ratio, 0.63 [CI, 0.51 to 0.86]; hazard ratio adjusted for weight change, 0.70 [CI, 0.59 to 0.90]; P < 0.001). Participants assigned to the Mediterranean-style diet lost more weight and experienced greater improvements in some glycemic control and coronary risk measures than did those assigned to the low-fat diet. LIMITATIONS: Investigators responsible for initiating drug therapy were not blinded to treatment assignment. Dietary intake was self-reported.
CONCLUSION: Compared with a low-fat diet, a low-carbohydrate, Mediterranean-style diet led to more favorable changes in glycemic control and coronary risk factors and delayed the need for antihyperglycemic drug therapy in overweight patients with newly diagnosed type 2 diabetes. PRIMARY FUNDING SOURCE: Second University of Naples.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19721018     DOI: 10.7326/0003-4819-151-5-200909010-00004

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  110 in total

1.  Egg consumption and risk of type 2 diabetes in older adults.

Authors:  Luc Djoussé; Aruna Kamineni; Tracy L Nelson; Mercedes Carnethon; Dariush Mozaffarian; David Siscovick; Kenneth J Mukamal
Journal:  Am J Clin Nutr       Date:  2010-06-09       Impact factor: 7.045

Review 2.  Standards of medical care in diabetes--2012.

Authors: 
Journal:  Diabetes Care       Date:  2012-01       Impact factor: 19.112

3.  New Diabetes Nutrition Therapy Recommendations: What You Need to Know.

Authors:  Alison B Evert; Jackie L Boucher
Journal:  Diabetes Spectr       Date:  2014-05

4.  Mediterranean diet for type 2 diabetes: cardiometabolic benefits.

Authors:  Katherine Esposito; Maria Ida Maiorino; Giuseppe Bellastella; Demosthenes B Panagiotakos; Dario Giugliano
Journal:  Endocrine       Date:  2016-07-09       Impact factor: 3.633

Review 5.  Update on the treatment of type 2 diabetes mellitus.

Authors:  Juan José Marín-Peñalver; Iciar Martín-Timón; Cristina Sevillano-Collantes; Francisco Javier Del Cañizo-Gómez
Journal:  World J Diabetes       Date:  2016-09-15

Review 6.  More sugar? No, thank you! The elusive nature of low carbohydrate diets.

Authors:  Dario Giugliano; Maria Ida Maiorino; Giuseppe Bellastella; Katherine Esposito
Journal:  Endocrine       Date:  2018-03-19       Impact factor: 3.633

Review 7.  Comprehensive Cardiovascular Risk Reduction and Cardiac Rehabilitation in Diabetes and the Metabolic Syndrome.

Authors:  Robert E Heinl; Devinder S Dhindsa; Elliot N Mahlof; William M Schultz; Johnathan C Ricketts; Tina Varghese; Amirhossein Esmaeeli; Marc P Allard-Ratick; Anthony J Millard; Heval M Kelli; Pratik B Sandesara; Danny J Eapen; Laurence Sperling
Journal:  Can J Cardiol       Date:  2016-07-22       Impact factor: 5.223

8.  [Nutrition for diabetic patients].

Authors:  Karin Schindler; Bernhard Ludvik
Journal:  Wien Klin Wochenschr       Date:  2012-12       Impact factor: 1.704

9.  Macronutrient Intake, Diagnosis Status, and Glycemic Control Among US Hispanics/Latinos With Diabetes.

Authors:  Xueyin Wang; Molly Jung; Yasmin Mossavar-Rahmani; Daniela Sotres-Alvarez; Rebeca A Espinoza Giacinto; Amber Pirzada; Samantha A Reina; Sarah S Casagrande; Tao Wang; M Larissa Avilés-Santa; Robert C Kaplan; Qibin Qi
Journal:  J Clin Endocrinol Metab       Date:  2016-03-07       Impact factor: 5.958

10.  Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Melanie J Davies; David A D'Alessio; Judith Fradkin; Walter N Kernan; Chantal Mathieu; Geltrude Mingrone; Peter Rossing; Apostolos Tsapas; Deborah J Wexler; John B Buse
Journal:  Diabetologia       Date:  2018-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.